10482 related articles for article (PubMed ID: 15223777)
1. Interferon alpha 2b decreases hepatic micrometastasis in a murine model of ocular melanoma by activation of intrinsic hepatic natural killer cells.
Yang H; Dithmar S; Grossniklaus HE
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2056-64. PubMed ID: 15223777
[TBL] [Abstract][Full Text] [Related]
2. Low dose adjuvant angiostatin decreases hepatic micrometastasis in murine ocular melanoma model.
Yang H; Akor C; Dithmar S; Grossniklaus HE
Mol Vis; 2004 Dec; 10():987-95. PubMed ID: 15623988
[TBL] [Abstract][Full Text] [Related]
3. [Metastatic uveal melanoma. Development of neoadjuvant treatment in animal experiments].
Dithmar S; Adams AW; Rusciano D; Grossniklaus HE
Ophthalmologe; 2001 Aug; 98(8):761-5. PubMed ID: 11552416
[TBL] [Abstract][Full Text] [Related]
4. Combined immunologic and anti-angiogenic therapy reduces hepatic micrometastases in a murine ocular melanoma model.
Yang H; Grossniklaus HE
Curr Eye Res; 2006 Jun; 31(6):557-62. PubMed ID: 16769615
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant interferon alfa-2b treatment in a murine model for metastatic ocular melanoma: a preliminary study.
Dithmar S; Rusciano D; Lynn MJ; Lawson DH; Armstrong CA; Grossniklaus HE
Arch Ophthalmol; 2000 Aug; 118(8):1085-9. PubMed ID: 10922203
[TBL] [Abstract][Full Text] [Related]
6. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model.
Ma D; Luyten GP; Luider TM; Niederkorn JY
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):435-41. PubMed ID: 7843912
[TBL] [Abstract][Full Text] [Related]
7. Depletion of NK cell activity results in growth of hepatic micrometastases in a murine ocular melanoma model.
Dithmar SA; Rusciano DA; Armstrong CA; Lynn MJ; Grossniklaus HE
Curr Eye Res; 1999 Nov; 19(5):426-31. PubMed ID: 10520219
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells and pigment epithelial-derived factor control the infiltrative and nodular growth of hepatic metastases in an Orthotopic murine model of ocular melanoma.
Jones NM; Yang H; Zhang Q; Morales-Tirado VM; Grossniklaus HE
BMC Cancer; 2019 May; 19(1):484. PubMed ID: 31117965
[TBL] [Abstract][Full Text] [Related]
9. Reduction of liver metastasis of intraocular melanoma by interferon-beta gene transfer.
Alizadeh H; Howard K; Mellon J; Mayhew E; Rusciano D; Niederkorn JY
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3042-51. PubMed ID: 12824250
[TBL] [Abstract][Full Text] [Related]
10. The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism.
Yang H; Brackett CM; Morales-Tirado VM; Li Z; Zhang Q; Wilson MW; Benjamin C; Harris W; Waller EK; Gudkov AV; Burdelya LG; Grossniklaus HE
Oncotarget; 2016 Jan; 7(3):2936-50. PubMed ID: 26655090
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice.
Nakagawa R; Nagafune I; Tazunoki Y; Ehara H; Tomura H; Iijima R; Motoki K; Kamishohara M; Seki S
J Immunol; 2001 Jun; 166(11):6578-84. PubMed ID: 11359810
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis.
Ma D; Niederkorn JY
Immunology; 1995 Oct; 86(2):263-9. PubMed ID: 7490128
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma.
Yang H; Jager MJ; Grossniklaus HE
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):2835-42. PubMed ID: 20089875
[TBL] [Abstract][Full Text] [Related]
14. NKT cells act through third party bone marrow-derived cells to suppress NK cell activity in the liver and exacerbate hepatic melanoma metastases.
Sadegh L; Chen PW; Brown JR; Han Z; Niederkorn JY
Int J Cancer; 2015 Sep; 137(5):1085-94. PubMed ID: 25683463
[TBL] [Abstract][Full Text] [Related]
15. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
16. Analysis of metastatic spread and growth of tumor cells in mice with depressed natural killer activity by anti-asialo GM1 antibody or anticancer agents.
Saijo N; Ozaki A; Beppu Y; Takahashi K; Fujita J; Sasaki Y; Nomori H; Kimata M; Shimizu E; Hoshi A
J Cancer Res Clin Oncol; 1984; 107(3):157-63. PubMed ID: 6736102
[TBL] [Abstract][Full Text] [Related]
17. TNF impairs in vivo and in vitro natural killer (NK) susceptibility of B16 melanoma cells.
Palmieri G; Morrone S; Lollini PL; De Giovanni C; Nicoletti G; Nanni P; Frati L; Santoni A
Scand J Immunol; 1992 Mar; 35(3):279-87. PubMed ID: 1535986
[TBL] [Abstract][Full Text] [Related]
18. Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma.
Markovic SN; Murasko DM
Cancer Res; 1991 Feb; 51(4):1124-8. PubMed ID: 1705166
[TBL] [Abstract][Full Text] [Related]
19. NKT cell exacerbation of liver metastases arising from melanomas transplanted into either the eyes or spleens of mice.
Yang W; Li H; Mayhew E; Mellon J; Chen PW; Niederkorn JY
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3094-102. PubMed ID: 21330669
[TBL] [Abstract][Full Text] [Related]
20. Effect of in vivo activation of natural killer (NK) cells by a tilorone analogue on the survival of mice injected intravenously with different experimental murine tumours.
Algarra I; González A; Pérez M; Gaforio JJ; Garrido F
Clin Exp Immunol; 1996 Mar; 103(3):499-505. PubMed ID: 8608652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
